Bando, H., Watanabe, J., Kotaka, M., Matsuhashi, N., Oki, E., Komatsu, Y., Shiozawa, M., Hirata, K., Miyamoto, Y., Yeh, K., Aleshin, A., Takemasa, I., Kotani, D., Sato, A., Misumi, T., Nakamura, Y., Shi, Q., Taniguchi, H., Kato, T., Yoshino, T. (2025). A randomized, double-blind, phase III study comparing trifluridine/tipiracil (FTD/TPI) versus placebo in patients with molecular residual disease following curative resection of colorectal cancer (CRC): The ALTAIR study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.lba22